Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Hospira Oncology gets EIR for its Ahmedabad facility

      Zydus Hospira Oncology gets EIR for its Ahmedabad facility

      Ruby Khatun Khatun15 July 2018 10:15 AM IST
      New Delhi: Drug firm Zydus Cadila said Zydus Hospira Oncology, a JV between the company and Hospira Inc, has received Establishment Inspection Report...
      Invest in research and development: Suresh Prabhu tells pharma companies

      Invest in research and development: Suresh Prabhu tells pharma companies

      Ruby Khatun Khatun15 July 2018 10:00 AM IST
      New Delhi: Commerce and Industry Minister Suresh Prabhu asked pharmaceutical companies to invest in research and development (R&D) to bolster the...
      USD 550 million awarded in lawsuit linking cancer, baby powder

      USD 550 million awarded in lawsuit linking cancer, baby powder

      Ruby Khatun Khatun15 July 2018 9:45 AM IST
      R St Louis (US): Nearly two dozen women who claimed asbestos in Johnson and Johnson talcum powder caused their ovarian cancer was awarded USD 550...
      With US trade under a cloud, China opens to Indian pharma

      With US trade under a cloud, China opens to Indian pharma

      Ruby Khatun Khatun15 July 2018 9:30 AM IST
      New Delhi: China is preparing to give swift regulatory approvals to India-manufactured drugs, the head of an Indian export promotion group said, as...
      Rs 47 crore Penalty on Glenmark Pharma, other entities for unfair business practices

      Rs 47 crore Penalty on Glenmark Pharma, other entities for unfair business practices

      Ruby Khatun Khatun14 July 2018 4:43 PM IST
      New Delhi: The Competition Commission on Friday imposed penalties totaling nearly Rs 47 crore on Glenmark Pharmaceutical, its three officials, two...
      Fortis will grow stronger under IHH ownership: Singh brothers

      Fortis will grow stronger under IHH ownership: Singh brothers

      Ruby Khatun Khatun14 July 2018 10:45 AM IST
      New Delhi: Former Fortis promoters, Singh brothers said the hospital chain will grow stronger under the new ownership of IHH Healthcare.Similarly,...
      Zydus Cadila receives USFDA approval for migraine relief drug

      Zydus Cadila receives USFDA approval for migraine relief drug

      Ruby Khatun Khatun14 July 2018 10:15 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Zolmitriptan tablets, used to relieve headache, pain, and...
      Shilpa Medicare gets Establishment Inspection Report from USFDA for Raichur facility

      Shilpa Medicare gets Establishment Inspection Report from USFDA for Raichur facility

      Ruby Khatun Khatun14 July 2018 10:15 AM IST
      New Delhi: Shilpa Medicare said the US health regulator has issued an establishment inspection report (EIR) for its Raichur facility in Karnataka."We...
      Alembic Pharma gets tentative USFDA approval for Ticagrelor tablets

      Alembic Pharma gets tentative USFDA approval for Ticagrelor tablets

      Ruby Khatun Khatun14 July 2018 10:00 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals has received tentative approval from the US health regulator for Ticagrelor tablets, used to reduce the...
      Pfizer separates consumer health unit in business rejig

      Pfizer separates consumer health unit in business rejig

      Ruby Khatun Khatun14 July 2018 9:45 AM IST
      Pfizer Inc announced plans to reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell...
      Zogenixs seizure drug clears late-stage trial

      Zogenix's seizure drug clears late-stage trial

      Ruby Khatun Khatun14 July 2018 9:30 AM IST
      Zogenix Inc said its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial.The successful trial...
      IHH Healthcare: Meet the Highest Bidder of Fortis Healthcare

      IHH Healthcare: Meet the Highest Bidder of Fortis Healthcare

      Ruby Khatun Khatun13 July 2018 5:37 PM IST
      New Delhi: After months of searching for an investor, cash-strapped Fortis Healthcare said its board unanimously accepted a binding offer from...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok